My graduate studies included learning about constraint-based optimization algorithms (such as linear programming) and ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Abstract: Combining the use of the adaptive dynamic programming method and optimized backstepping strategy, this paper focuses on the secure consensus problem for constrained nonlinear multi-agent ...